These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29599339)
1. Depth of Seder CW; Mahon B; Hennon M; Thomas M; Levea CM; Matkowskyj KA; Krishna M; Medairos R; Macke RA; Basu S; Blasberg JD Anticancer Res; 2018 Apr; 38(4):2195-2200. PubMed ID: 29599339 [TBL] [Abstract][Full Text] [Related]
2. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311 [TBL] [Abstract][Full Text] [Related]
3. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659 [TBL] [Abstract][Full Text] [Related]
4. Impact of deep muscle invasion on nodal status and survival in patients with pT2 esophageal squamous cancer. Yan CY; Gu YM; Shi GD; Shang QX; Zhang HL; Yang YS; Wang WP; Yuan Y; Chen LQ J Surg Oncol; 2024 May; 129(6):1056-1062. PubMed ID: 38314575 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma. Duan J; Deng T; Ying G; Zhang H; Zhou L; Bai M; Li H; Ba Y Dis Esophagus; 2017 Apr; 30(4):1-7. PubMed ID: 28375473 [TBL] [Abstract][Full Text] [Related]
6. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. Sepesi B; Watson TJ; Zhou D; Polomsky M; Litle VR; Jones CE; Raymond DP; Hu R; Qiu X; Peters JH J Am Coll Surg; 2010 Apr; 210(4):418-27. PubMed ID: 20347733 [TBL] [Abstract][Full Text] [Related]
7. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Liu L; Hofstetter WL; Rashid A; Swisher SG; Correa AM; Ajani JA; Hamilton SR; Wu TT Am J Surg Pathol; 2005 Aug; 29(8):1079-85. PubMed ID: 16006804 [TBL] [Abstract][Full Text] [Related]
8. Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma. Barbetta A; Schlottmann F; Nobel T; Sewell DB; Hsu M; Tan KS; Gerdes H; Shah P; Bains MS; Bott M; Isbell JM; Jones DR; Molena D Ann Thorac Surg; 2018 Jul; 106(1):172-177. PubMed ID: 29627387 [TBL] [Abstract][Full Text] [Related]
9. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142 [TBL] [Abstract][Full Text] [Related]
10. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma. Lewis JT; Wang KK; Abraham SC Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796 [TBL] [Abstract][Full Text] [Related]
11. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Maish MS; DeMeester SR Ann Thorac Surg; 2004 Nov; 78(5):1777-82. PubMed ID: 15511474 [TBL] [Abstract][Full Text] [Related]
12. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229 [TBL] [Abstract][Full Text] [Related]
13. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation. Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488 [TBL] [Abstract][Full Text] [Related]
14. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW; J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058 [TBL] [Abstract][Full Text] [Related]
15. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186 [TBL] [Abstract][Full Text] [Related]
16. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus. Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508 [TBL] [Abstract][Full Text] [Related]
18. pT2 Adenocarcinoma of the esophagus: early or advanced cancer? Metzger R; Lorenz D; Gockel I; Origer J; Plum PS; Junginger T; Drebber U; Hansen T; Krümpelmann K; Fisseler-Eckhoff A; Lang H; Hölscher AH; Bollschweiler E Ann Thorac Surg; 2013 Nov; 96(5):1840-5. PubMed ID: 23987902 [TBL] [Abstract][Full Text] [Related]
19. Intramucosal esophageal adenocarcinoma: primum non nocere. Li Z; Rice TW; Liu X; Goldblum JR; Williams SJ; Rybicki LA; Murthy SC; Mason DP; Raymond DP; Blackstone EH J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1519-24, 1524.e1-3. PubMed ID: 23158254 [TBL] [Abstract][Full Text] [Related]